These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33632587)

  • 21. Reflexive and volitional saccadic eye movements and their changes in age and progressive supranuclear palsy.
    Wright IH; Sekar A; Jensen MT; Hodgson M; Bancroft MJ; Koohi N; Lees AJ; Morris HR; Kaski D
    J Neurol Sci; 2022 Dec; 443():120482. PubMed ID: 36356484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic potential of dentatorubrothalamic tract analysis in progressive supranuclear palsy.
    Seki M; Seppi K; Mueller C; Potrusil T; Goebel G; Reiter E; Nocker M; Steiger R; Wildauer M; Gizewski ER; Wenning GK; Poewe W; Scherfler C
    Parkinsonism Relat Disord; 2018 Apr; 49():81-87. PubMed ID: 29463454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic value of video-oculography in progressive supranuclear palsy: a controlled study in 100 patients.
    Wunderlich J; Behler A; Dreyhaupt J; Ludolph AC; Pinkhardt EH; Kassubek J
    J Neurol; 2021 Sep; 268(9):3467-3475. PubMed ID: 33744980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective Characterization of Cognitive Function in Typical and 'Brainstem Predominant'Progressive Supranuclear Palsy Phenotypes.
    Lee YC; Williams DR; Anderson JFI
    J Mov Disord; 2018 May; 11(2):72-77. PubMed ID: 29860785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Visual fixation suppression of caloric nystagmus in progressive supranuclear palsy - A comparison with Parkinson's disease.
    Naito R; Watanabe Y; Naito A; Sugasawa K; Nakata Y; Kamiyama T; Okiyama R; Yokochi F; Isozaki E; Yamasoba T; Takahashi K
    J Vestib Res; 2023; 33(6):385-401. PubMed ID: 37599554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "Parkinson's disease" on the way to progressive supranuclear palsy: a review on PSP-parkinsonism.
    Necpál J; Borsek M; Jeleňová B
    Neurol Sci; 2021 Dec; 42(12):4927-4936. PubMed ID: 34532773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eye tracking identifies biomarkers in α-synucleinopathies versus progressive supranuclear palsy.
    Habibi M; Oertel WH; White BJ; Brien DC; Coe BC; Riek HC; Perkins J; Yep R; Itti L; Timmermann L; Best C; Sittig E; Janzen A; Munoz DP
    J Neurol; 2022 Sep; 269(9):4920-4938. PubMed ID: 35501501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cerebral blood flow and oxygen metabolism in patients with pure akinesia and progressive supranuclear palsy].
    Kondo S; Tanaka M; Sun X; Okamoto K; Hirai S
    Rinsho Shinkeigaku; 1994 Jun; 34(6):531-7. PubMed ID: 7955710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Theta burst stimulation modulates cerebellar-cortical connectivity in patients with progressive supranuclear palsy.
    Brusa L; Ponzo V; Mastropasqua C; Picazio S; Bonnì S; Di Lorenzo F; Iani C; Stefani A; Stanzione P; Caltagirone C; Bozzali M; Koch G
    Brain Stimul; 2014; 7(1):29-35. PubMed ID: 23928103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abnormal saccade profiles in hereditary spinocerebellar degeneration reveal cerebellar contribution to visually guided saccades.
    Inomata-Terada S; Fukuda H; Tokushige SI; Matsuda SI; Hamada M; Ugawa Y; Tsuji S; Terao Y
    Clin Neurophysiol; 2023 Oct; 154():70-84. PubMed ID: 37572405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The auditory startle response in parkinsonism may reveal the extent but not type of pathology.
    Williams DR; Doyle LM; Lees AJ; Brown P
    J Neurol; 2008 May; 255(5):628-32. PubMed ID: 18283396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simple linear brainstem MRI measurements in the differential diagnosis of progressive supranuclear palsy from the parkinsonian variant of multiple system atrophy.
    Constantinides VC; Paraskevas GP; Stamboulis E; Kapaki E
    Neurol Sci; 2018 Feb; 39(2):359-364. PubMed ID: 29196955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gradient subthalamic neurodegeneration and tau pathology in the hypoglossal nucleus as essential pathological markers of progressive supranuclear palsy - Richardson syndrome.
    Homma T; Mochizuki Y; Hara M; Kamei S; Mizutani T; Takubo H; Isozaki E; Takahashi M; Komori T; Hao H
    Rev Neurol (Paris); 2020 May; 176(5):353-360. PubMed ID: 32247606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PDQ-8: A Simplified and Effective Tool Measuring Life Quality in Progressive Supranuclear Palsy.
    Li XY; Chen MJ; Liang XN; Yao RX; Shen B; Wu B; Li G; Sun YM; Wu JJ; Liu FT; Yang YJ; Wang J;
    J Parkinsons Dis; 2023; 13(1):83-91. PubMed ID: 36591660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PSP-Richardson syndrome mimics: An overview and pragmatic approach.
    Necpál J; Borsek M; Jeleňová B
    Rev Neurol (Paris); 2024; 180(1-2):12-23. PubMed ID: 37543508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imaging counterpart of postural instability and vertical ocular dysfunction in patients with PSP: A multimodal MRI study.
    Quattrone A; Caligiuri ME; Morelli M; Nigro S; Vescio B; Arabia G; Nicoletti G; Nisticò R; Salsone M; Novellino F; Barbagallo G; Vaccaro MG; Sabatini U; Vescio V; Stanà C; Rocca F; Caracciolo M; Quattrone A
    Parkinsonism Relat Disord; 2019 Jun; 63():124-130. PubMed ID: 30803901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal ocular motor study in corticobasal degeneration and progressive supranuclear palsy.
    Rivaud-Péchoux S; Vidailhet M; Gallouedec G; Litvan I; Gaymard B; Pierrot-Deseilligny C
    Neurology; 2000 Mar; 54(5):1029-32. PubMed ID: 10720270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diffusion tractography of superior cerebellar peduncle and dentatorubrothalamic tracts in two autopsy confirmed progressive supranuclear palsy variants: Richardson syndrome and the speech-language variant.
    Gatto RG; Martin PR; Ali F; Clark HM; Duffy JR; Utianski RL; Botha H; Machulda MM; Dickson DW; Josephs KA; Whitwell JL
    Neuroimage Clin; 2022; 35():103030. PubMed ID: 35597031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progression of two Progressive Supranuclear Palsy phenotypes with comparable initial disability.
    Shoeibi A; Litvan I; Tolosa E; Ser TD; Lee E;
    Parkinsonism Relat Disord; 2019 Sep; 66():87-93. PubMed ID: 31307919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration.
    Gröschel K; Hauser TK; Luft A; Patronas N; Dichgans J; Litvan I; Schulz JB
    Neuroimage; 2004 Feb; 21(2):714-24. PubMed ID: 14980574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.